David Kirn
Known title: See RemarksCIK: 0001834021
Associated companies
Transaction History
| FDMT | ▼ Sell | Open Market | 58,061 | $750K | 10/5/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 272 | $4K | 10/5/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 58,333 | $811K | 9/14/2026 | View on chart |
| FDMT | ▲ Buy | Option Exercise | 50,000 | $207K | 8/19/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 43,149 | $663K | 8/19/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 25,927 | $426K | 8/19/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 26,842 | $275K | 8/4/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 12,415 | $125K | 8/3/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 15,283 | $184K | 7/10/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 442 | $6K | 7/10/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 42,608 | $548K | 7/9/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 114,746 | $1.2M | 6/22/2026 | View on chart |
| FDMT | ▼ Sell | Open Market | 1,922 | $19K | 6/1/2026 | View on chart |
| FDMT | ▲ Buy | Option Exercise | 11,653 | $168K | 7/10/2024 | View on chart |
| FDMT | ▲ Buy | Option Exercise | 1,270 | $20K | 7/10/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 12,923 | $291K | 7/10/2024 | View on chart |
| FDMT | ▲ Buy | Option Exercise | 12,930 | $186K | 6/24/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 12,930 | $299K | 6/24/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 92,001 | $2.5M | 2/8/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 5,696 | $105K | 1/23/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 28,104 | $550K | 1/5/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 133 | $3K | 1/5/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 40,732 | $827K | 1/4/2024 | View on chart |
| FDMT | ▼ Sell | Open Market | 4,702 | $85K | 12/18/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 28,632 | $494K | 12/15/2023 | View on chart |
| FDMT | ▼ Sell | Gift | 600,000 | $0 | 5/2/2023 | View on chart |
| FDMT | ▼ Sell | Gift | 600,000 | $0 | 5/2/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 16,449 | $333K | 2/22/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 17,090 | $358K | 2/21/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 907 | $19K | 2/21/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 8,625 | $174K | 1/20/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 10,899 | $218K | 1/19/2023 | View on chart |
| FDMT | ▼ Sell | Open Market | 27,595 | $625K | 12/16/2022 | View on chart |
| FDMT | ▼ Sell | Open Market | 26,349 | $616K | 12/16/2022 | View on chart |
| FDMT | ▼ Sell | Open Market | 31,433 | $741K | 12/15/2022 | View on chart |
| FDMT | ▼ Sell | Open Market | 1,500 | $36K | 12/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
FDMT listed in Benzinga pre-market movers
4D Molecular Therapeutics was mentioned in a Benzinga report on stocks moving lower in Friday’s pre-market session. The article grouped FDMT with other companies like Scholastic and Zscaler, noting a generally downbeat tone among legacy education and other large-cap names. This indicates the stock was part of a broader market movement rather than reacting to a company-specific announcement.
FDMT listed in Benzinga pre-market movers. 4D Molecular Therapeutics was mentioned in a Benzinga report on stocks moving lower in Friday’s pre-market session. The article grouped FDMT with other companies like Scholastic and Zscaler, noting a generally downbeat tone among legacy education and other large-cap names. This indicates the stock was part of a broader market movement rather than reacting to a company-specific announcement.